Advertisement
Screener

InnovAge Holding Corp. (INNV) EBITDA

InnovAge Holding Corp. (INNV) EBITDA

  • 2026-03-31: Basis Reported; EBITDA -$24.26M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $18.14M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $13.37M; Operating income (m); Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA $1.24M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-03-31Reported-$24.26M(m)(m)(m)(m)$3.60M*$18.14M*(m)(m)(m)$167.00K
2025-12-31Reported$18.14M(m)(m)(m)(m)$2.36M*$21.36M*(m)(m)(m)$651.00K
2025-09-30Reported$13.37M(m)(m)(m)(m)$4.08M$3.92M(m)(m)(m)$247.00K
2025-06-30Reported$1.24M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-03-31Reported-$4.77M(m)(m)(m)(m)$2.90M*$24.63M*(m)(m)(m)$72.00K
2024-12-31Reported-$7.24M(m)(m)(m)(m)$1.34M*$6.75M*(m)(m)(m)$34.00K
2024-09-30Reported$514,000.00(m)(m)(m)(m)$2.20M-$7.52M(m)(m)(m)$404.00K
2024-06-30Reported$446,000.00(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-03-31Reported-$731,000.00(m)(m)(m)(m)$452.00K*$3.51M*(m)(m)(m)-$224.00K
2023-12-31Reported$2.51M(m)(m)(m)(m)$1.59M*-$9.29M*(m)(m)(m)$93.00K
2023-09-30Reported-$6.45M(m)(m)(m)(m)$2.57M-$32.98M(m)(m)(m)$226.00K
2023-06-30Reported-$6.61M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-03-31Reported-$4.18M(m)(m)(m)(m)$4.70M*$29.07M*(m)(m)(m)-$1.36M
2022-12-31Reported-$10.02M(m)(m)(m)(m)$6.97M*-$35.12M*(m)(m)(m)-$2.91M
2022-09-30Reported-$13.17M(m)(m)(m)(m)$7.67M$13.13M(m)(m)(m)-$3.47M
2022-06-30Reported-$8.86M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31Reported-$2.82M(m)(m)(m)(m)$8.46M*-$7.52M*(m)(m)(m)-$4.12M
2021-12-31Reported$6.25M(m)(m)(m)(m)$8.64M*$11.02M*(m)(m)(m)$1.20M
2021-09-30Reported$14.95M(m)(m)(m)(m)$3.04M$20.56M(m)(m)(m)$3.00M
2021-06-30Reported$13.7M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31Reported-$2.06M(m)(m)(m)(m)$2.62M*-$16.29M*(m)(m)(m)-$4.26M
2020-12-31Reported$23.53M(m)(m)(m)(m)$6.83M*$17.32M*(m)(m)(m)$4.49M
2020-09-30Reported-$35.22M(m)(m)(m)(m)$4.63M-$18.06M(m)(m)(m)$4.94M
2020-06-30Reported$23.15M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31Reported$15.74M(m)(m)(m)(m)(m)(m)(m)(m)(m)$2.87M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$23.76M*$2.62M$21.14M$989.71M2.40%*$14.31M$64.71M(m)(m)(m)$949.00K
2025-06-30Reported-$10.25M(m)(m)(m)(m)$6.26M$32.87M(m)(m)(m)$1.32M
2024-06-30Reported-$4.23M(m)(m)(m)(m)$7.91M-$36.90M(m)(m)(m)$1.40M
2023-06-30Reported-$33.98M(m)(m)(m)(m)$23.35M$20.24M(m)(m)(m)-$7.24M
2022-06-30Reported$9.52M(m)(m)(m)(m)$38.24M$27.30M(m)(m)(m)$723.00K
2021-06-30Reported-$43,000.00(m)(m)(m)(m)$17.54M-$7.55M(m)(m)(m)$9.77M
2020-06-30Reported$62.22M(m)(m)(m)(m)$11.84M$43.83M(m)(m)(m)$9.87M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Omada Health, Inc. (OMDA)United States$1.207B309.08
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86